CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PANACEA project focuses on creating a novel biomaterial platform to improve treatment for primary bone cancers in children and adolescents. By integrating a collagen scaffold with reduced graphene oxide, it aims to enhance bone regeneration while simultaneously targeting cancer cells through innovative delivery met…
Primary bone cancers are aggressive malignancies that characteristically arise during childhood/adolescence.
Current treatment involves a multidimensional approach of surgery and chemotherapy but response to therapy can be poor-about 30% of primary bone cancer patients die within 5 years.
Despite treatment with various chemotherapy regimens in the past 20 years, survival rates have notimproved and no efficacious targeted therapies have been developed.
Bone tumours also often colonise large expan…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
